Background/Aims: Increasing evidence has demonstrated the novel roles of mesenchymal stem cells (MSCs) in immunotherapy. However, difficulty in acquiring these cells and possible ethical issues limited their application. Recently, we have isolated a unique MSC population from dental follicles with potent stem cell-like properties. This study focused on the effects of dental follicle stem cells (DFSCs) on macrophage activation and polarization to determine their role in immunomodulation and to test if DFSCs are a promising cell source for MSC-based immunotherapy. Methods: Rat acute lung injury (ALI) models induced by Lipopolysaccharide (LPS) were applied to test the immune-modulatory effects of DFSC/DFSC-CM in vivo. The pulmonary permeability was determined by the dry / wet weight ratios of the left upper lung lobe. The lung histopathological damage was graded on a 0 to 4+ scale. And the inflammatory cytokines in bronchoalveolar lavage fluid (BALF) were tested by ELISA. Then we established LPS-induced inflamed macrophage models in vitro. Inflammatory cytokine production and polarization marker expression were measured by RT-qPCR, ELISA, western blot and flow cytometric analysis in macrophages following DFSC-CM treatment. The paracrine factors in DFSC-CM were revealed by a RayBiotech Protein Array. Thereafter, neutralization studies were performed to confirm the potential immune regulators in DFSC-CM. Results: The DFSC/DFSC-CM not only attenuated histopathological damage and pulmonary permeability, but also downregulated pro-inflammatory cytokines MCP-1, IL-1, IL-6 and TNF-α, and upregulated anti-inflammatory cytokine IL-10 in BALF. Immunofluorescence staining revealed 
Introduction
Macrophages consist in basically all tissues. They are cellular components of the innate immune systems, ingesting and degrading dead cells, debris, and foreign material and orchestrating inflammatory processes [1] [2] [3] . They play a crucial role in tissue homeostasis, key immunological processes and the development of various diseases [4, 5] . Activated macrophages are critical for the clearance of invading pathogens and their toxic products and classified into M1 and M2 types [6] . M1 macrophages, which produce high levels of proinflammatory cytokines, nitric oxide (NO), and reactive oxygen species [7] , are implicated in initiating and sustaining inflammation. However, the M2 subtype generates high levels of anti-inflammatory cytokines such as IL-10, TGF-β1 and PDGF [8] and facilitates antiinflammatory activity [1] . The balance between M1 and M2 macrophages is essential for homeostasis, and a shift from M1-rich to M2-rich macrophages alleviates inflammatory processes and promotes tissue repair and regeneration [9, 10] . Therefore, inducing M1 to M2 switch in macrophages may be of vital importance and have promising applications in immunotherapy.
MSCs represent a heterogeneous population of spindle-shaped stromal cells, with selfrenewal and colony-forming properties and multipotent differentiation capacities [11] . MSCs possess the unique ability of homing to inflammatory sites guided by various growth factors and cytokines so that the tissue may be repaired [12, 13] . Recently, MSCs have been shown to regulate immune responses by suppressing the proliferation and activation of T and B cells, and promote the generation of regulatory T cells, manifesting the immunosuppressive functions [13, 14] . In addition, MSCs elicit a phenotypic switch from M1 to M2 macrophages in vitro [15, 16] as well as in animal models of acute kidney injury [17] , experimental colitis [18] , spinal cord injury [19] , and skin wounds [1] . MSCs affect neighboring immune cells primarily through direct cell-to-cell contact and/or various soluble factors [12] [13] [14] 20] . These novel properties indicate that MSCs are promising candidates in cell-based therapies for a variety of immune and inflammation-related diseases [12] [13] [14] . There are several clinical trials of MSCs for the treatment of immune and inflammation-related diseases, such as lupus erythematosus (NCT03171194), primary immunodeficiency diseases (NCT02579967), inflammatory bowel disease (NCT01851343), osteoarthritis (NCT02666443), ischemic disease (NCT03225625) and so on. Bone marrow is currently the most common source of MSCs [21] . However, difficulty in acquiring these cells and possible ethical issues limited their application. Therefore, there is an urgent need to find alternatives with easy access and reduced damage.
Recently, oral cavity have been paid more and more attention to gaining somatic stem cells as it's more flexible for the surgeons to harvest the tissues without undue trauma to the patients [22, 23] . Among them, the odontogenic stem cells are derived from extracted teeth in dentistry such as deciduous, orthodontic and wisdom teeth. They are much easier to harvest and do not cause any secondary harm to individuals. Therefore, less ethical issues are involved. There are many kinds of odontogenic stem cells, such as dental pulp stem cells (DPSCs), dental follicle stem cells (DFSCs), stem cells from human exfoliated deciduous teeth (SHEDs) and so on. A growing number of studies have shown the immunomodulatory capacities of oral-derived stem cells, especially DPSCs and SHEDs. For instance, researchers applied SHED-conditioned medium to treat experimental autoimmune encephalomyelitis [24] , rheumatoid arthritis [25] and systemic lupus erythematosus [26, 27] . The results showed that SHEDs had significantly reduced the tissue damage caused by autoimmune diseases. Possible mechanisms are the transplantation of SHEDs directly regulate the proportion of Th17 cells in T cells; on the other hand, the SHEDs paracrine factors directly inhibit inflammatory responses or indirectly facilitate M2 macrophages to exert inflammatory regulation. However, DFSCs exhibited an enhanced differentiation ability and could induce increased number of CD4
+

FoxP3
+ Treg cells and suppressed the proliferation of peripheral blood mononuclear cells compared with DPSCs and SHEDs [28] , suggesting that DFSCs might also have potent immune-regulation capability or even better. However, the effect of DFSCs on macrophage polarization remains unknown, which may be an important consideration in determining whether DFSCs can be used as novel alternative cells for MSCbased immunotherapy.
Recently, many studies reported that acute lung injury (ALI) animal model induced by Lipopolysaccharide (LPS) [29, 30] , which is a progressive clinical disease with high mortality and characterized by an excessive and uncontrolled inflammatory response, could be applied to test the immune-modulatory effects in vivo. The theory is that in the development of ALI, neutrophils and macrophages are activated to eliminate pathogens, however, it brings tissue damage by releasing antimicrobial compounds at the same time [31] . And the treatment like MSCs or cytokines may make a change in the whole process, such as promoting macrophage M2 polarization [32] .
In our previous study, we successfully isolated DFSCs from dental follicles and demonstrated that they highly expressed the reprogramming markers Oct-4, Sox-2 and MYC [33] . We also studied the modulation and differentiation of DFSCs [34] [35] [36] [37] . In order to learn comprehensively the immune modulating properties of DFSCs, here we investigated the immunomodulatory effects of DFSCs on macrophage activation and polarization under inflammatory conditions in LPS-induced rat ALI models, as well as in a rat macrophage cell line. Furthermore, we explored the possible immunomodulatory paracrine factors to clarify the potential mechanisms of DFSC-directed macrophage polarization switch.
Materials and Methods
Isolation and culture of DFSCs
DFSCs were isolated and cultured as previously described [38] . Briefly, dental follicle tissues were harvested from 7-day-old Sprague-Dawley (S-D) rats, which were purchased from the Laboratory Animal Center of Sun Yat-sen University. Isolated dental follicle tissues were washed and finely minced into 1 mm small pieces and then incubated in 3 mg/ml collagenase I (Sigma-Aldrich, USA) and 4 mg/ml Dispase II (Sigma-Aldrich, USA) for 30 min at 37°C. Explants were then transferred to T25 cell culture flasks and cultivated in α minimum essential medium (α-MEM, Gibco, USA), supplemented with 20% fetal bovine serum (FBS, Gibco, USA), 100 U/ml penicillin (Gibco, USA) and 100 mg/ml streptomycin (Gibco, USA) at 37°C in a 5% CO 2 humidified atmosphere. The medium was changed every three days. The DFSCs at the third to fifth passages were used in the following experiments.
Immunocytochemistry analysis
Immunocytochemistry analysis was performed according to standard protocols. In brief, the third passage cells were plated in 24-well plates (Corning, USA), the media were removed after the cells reached ≥ 80% confluence and the plates were washed three times with 1×PBS. Then, the cells were fixed with 4% paraformaldehyde (Sigma-Aldrich, USA) for 15 min at room temperature. After fixation, the cells were permeabilized with 0.5% Triton X-100 (Sigma-Aldrich, USA) for 10 min at room temperature. Next, the cells were incubated in blocking buffer (5% BSA, Thermo Fisher Scientific, USA) for 60 min. The plates were washed again and then incubated with anti-cytokeratin 1 antibody (Catalog#: ab93652, Abcam, USA) and anti-vimentin antibody (Catalog#: ab92547, Abcam, USA) overnight at 4°C. Then, the cells were incubated with secondary antibody (mouse anti-rabbit IgG; Proteintech, USA; 1:100) for 45 min at room temperature. Images were captured using an inverted microscope (Carl Zeiss, Germany). Negative controls were incubated with PBS instead of the primary antibodies. 
Evaluation of osteogenic and adipogenic capabilities of DFSCs
The DFSCs were loaded in 6-well plates (Corning, USA) at a cell density of 1 × 10 5 cells per well and cultured in α-MEM supplemented with 10% FBS. After the cells reached 80% confluence, the medium was changed to osteogenic medium (α-MEM supplemented with 10% FBS, 5 mM β-glycerophosphate, 100 nM dexamethasone, and 50 mg/ml ascorbic acid) or commercial adipogenic differentiation medium (Cyagen Biosciences, China) for the following 7 or 14 days, while α-MEM supplemented with 10% FBS was used in the control group. After 7 or 14 days of incubation, the cells were washed twice with PBS and fixed in 4% paraformaldehyde (Sigma-Aldrich, USA) for 30 min, followed by Alizarin Red staining (Cyagen Biosciences, China) to reveal calcium depositions or Oil Red O (Sigma-Aldrich, USA) for the evaluation of adipogenic differentiation. The cells were imaged with a Fluorescence Inversion Microscope System (Carl Zeiss, Germany).
Preparation of CM from DFSCs
Once the DFSCs reached 70% confluence, the cells were washed with PBS twice, and the culture medium was then changed to serum-free Ham's F-12K (Kaighn's) medium. The supernatant was collected at 24-h intervals. After centrifugation for 5 min at 1000 ×g and filtration through a 0.22 μm strainer (Millipore, USA), the collected medium was stored at -80°C immediately. It was mixed with an equal volume of serum free Ham's F-12K medium when used as DFSC-CM.
LPS-induced acute lung injury
Eight-week-old male S-D rats (n ≥ 6 per group) were anaesthetized with 10% chloral hydrate and injected through caudal vein with 2.5 mg/kg LPS [29] (Escherichia coli, Sigma-Aldrich, USA). Four hours post LPS-injection, rats were re-anesthetized and received a 50-µl tail intravenous instillation of DFSCs, DFSC-CM or Ham's F-12K medium. We ensured equivalence between DFSC-based and CM-based treatment by managing the same number of cells (400, 000 cells/50 µl medium) that produced 50 µl concentrated DFSC-CM. Rats were sacrificed by intraperitoneal injection of excess chloral hydrate at 24 h post-LPS for the next assessments.
Lung histological analysis
For histological examination, the lungs were fixed with 4% formaldehyde solution, embedded with paraffin, sectioned into 4-µm-thick serial sections and stained with hematoxylin and eosin (HE). Images were captured with Leica CTRMIC microscope, ten high-powered fields per lung were randomly selected and blindly scored based on a previously published protocol [39] . Accordingly, the samples were graded as follows: 0, which means normal, accounting for <15% of the space occupied by tissue and >85% occupied by alveolar space. 1+, 15%~25% occupied by tissue and 75%~85% occupied by alveolar space. 2+, 25%~50% 
Assessment of lung permeability
Pulmonary edema due to LPS-induced increased lung permeability was measured by calculating the dry / wet weight ratios of the left upper lung lobe according to a previously described method [40] . Briefly, freshly harvested lungs were weighed (wet weights), then placed in a drying oven at 55℃ for 48 hours, the dry weights were recorded, and the lung dry / wet weight ratios were calculated.
Bronchoalveolar Lavage Fluid (BALF) analysis
Lungs were perfused by injecting 2.5 ml of ice-cold PBS at 0.5-ml increments through a 20-gauge catheter inserted into the trachea. BALF was centrifuged at 400 g for 10 min and the concentrations of MCP-1, IL-1β, IL-6, TNF-ɑ and IL-10 in the supernatants was determined by ELISA kit (Catalog#: ab179886, ab100768, ab100772, ab100785, ab100765, Abcam, UK), according to the manufacturer's instructions. The absorbance at 450 nm was measured using a microplate reader (ImmunoMini NJ1000). Triplicate reaction and three separate experiments were performed.
Lung immunofluorescence staining
The lungs were removed, embedded in OCT compound (Sakura Finetek), and cut into 10-mm-thick sections on a cryostat (Leica). The sections were then permeabilized with 0.5% Triton X-100 (Sigma-Aldrich, USA) for 20 min at room temperature, incubated in blocking buffer (5% BSA, Thermo Fisher Scientific, USA) for 60 min. The sections were washed again and then incubated with the following primary antibodies: CD11b (1:100, Catalog#: ab8879, Abcam, USA) and Arg-1 (1:50, Catalog#: 93668S, CST, USA). Anti-rabbit IgG-Alexa Fluor 594 and anti-mouse IgG-Alexa Fluor 488 was used as the secondary antibody. Images were captured using a fluorescence microscope (Carl Zeiss, Germany). The average ratio of Arg-1/CD11b doublepositive cells was determined by counting ten random, non-overlapping fields at 200× magnification. At least five animals per group were used.
Real-time quantitative PCR assay
For gene expression experiments, the rat macrophage NR8383 cell line (Xiangf Bio, Shanghai, China) was loaded in 6-well plates (Corning, USA) at a cell density of 1 × 10 5 cells per well and cultured in Ham's F-12K medium supplemented with 20% FBS. After the cells reached 80% confluence, the medium was changed to Ham's F-12K medium or DFSC-CM, with or without LPS (0.5 mg/l, Sigma-Aldrich, USA). The cells were imaged with an inverted microscope system (Carl Zeiss, Germany). Then total RNA was isolated using TRIzol (Invitrogen, USA) at 12-h intervals, and the first-strand cDNA was synthesized using 2 μg total RNA and a TaKaRa RNA PCR kit. PCR primers are listed in Table 1 . The PCR reaction conditions were 95 °C for 5 min followed by 40 cycles at 95°C for 15 s and 60°C for 30 s. Triplicate reaction and three separate experiments were performed.
ELISA
The supernatants of cultured macrophages were collected following LPS (0.5 mg/l; Sigma-Aldrich, USA) stimulation for 24 h, and the concentrations of MCP-1, IL-1β, IL-6, TNF-ɑ and IL-10 were evaluated with commercially available ELISA kits mentioned above.
Flow cytometric analysis of macrophage polarization marker
For immunolabeling, cells were incubated with FITC-conjugated CD86 monoclonal antibody (Catalog#: 11-0860-82, ThermoFisher eBioscience, USA) and PEconjugated CD163 monoclonal antibody (Catalog#: MA5-16657, Invitrogen, USA) at 4°C for 30 min. After incubation, 
Western blot analysis
Western blots were performed according to standard protocols. Briefly, cells were lysed with RIPA Reagent (Pierce, USA) containing 1% proteinase inhibitor (Thermo Fisher Scientific, USA) on ice for 30 min. The supernatants were harvested after centrifugation for 30 min at 12, 000 ×g. The bicinchoninic acid (BCA; Biocolors, China) method was used for estimation of total protein content. Proteins were denatured and separated by 10% SDS-polyacrylamide gels and transferred onto nitrocellulose membranes (Millipore, USA). The membranes were blocked in 5% commercial skim milk at room temperature for 1 h and probed with primary antibodies for Arg-1 (Cell Signaling Technology, USA) and iNOS (Millipore, USA) at 1:1000 or β-actin (Abcam, USA) at 1:5000 at 4°C overnight, washed, and incubated with horseradish peroxidaseconjugated secondary antibodies (Cell Signaling Technology, USA) at room temperature for 1 h. The membranes were visualized by enhanced chemiluminescence (ECL; Millipore, USA), and densitometry was performed using ImageJ software (Version 1.50i, USA).
Protein analysis of DFSC-CM
The proteins secreted by DFSCs in the CM were analyzed by a protein array according to the manufacturer's instruction (RayBiotech, USA). Briefly, protein array membranes were blocked in blocking buffer for 30 min and then incubated with DFSC-CM or serum-free Ham's F-12K medium (Sigma-Aldrich, USA) at 4°C overnight. After being washed with washing buffer, membranes were incubated with biotinconjugated antibodies at room temperature for 2 h and then reacted with HRP-conjugated streptavidin (1:1000 dilution) at room temperature for 2 h. After incubation with detection buffer in the dark, the membranes were exposed to X-ray film, and the image was developed using a film scanner. The signal intensities were quantified by densitometry. Fold changes in protein expression were calculated.
DFSC-CM cytokine measurement and verification
The levels of TSP-1 and TGF-β3 in DFSC-CM were further confirmed by ELISA (Catalog#: CSB-E08764r and CSB-E17325r, Cusabio, China). For depletion of TSP-1 and/or TGF-β3 from DFSC-CM, anti-TSP-1 (Catalog#: NB100-2059, Novus Biologicals, USA) and/or anti-TGF-β3 (Catalog#: AF-243-NA, R&D, USA) antibodies were added to DFSC-CM. Quantitative PCR assay was performed to measure IL-6, TNF-α and IL-10 mRNA expression levels to determine the effects of the two factors on the transcription of inflammatory factors from macrophages. Western blot analysis was then performed to test the effect of the two factors on the expression levels of Arg-1 and iNOS in macrophages under inflammatory conditions.
Statistical analysis
Data are presented as the mean ± SEM of at least three independent experiments. Student's t tests were carried out for pair-wise comparisons. One-way analysis of variance with Bonferroni correction was used for multiple comparisons. Statistical significance was defined as P < 0.05 or 0.01 (indicated as * or **, respectively). PRISM software (Version 6.0, GraphPad Inc., La Jolla, CA) was used for data analysis. (Fig. 1B) . Immunohistochemistry analysis showed that DFSCs were positive for the MSC marker vimentin (Fig. 1C) and negative for cytokeratin (Fig. 1D) , which is a marker of epithelial cells. Flow cytometric analysis showed that the DFSCs expressed high levels of the MSC markers CD29 (99.97%), CD44 (99.71%) and CD90 (99.99%) and were negative for the hematopoietic markers CD34 (0.41%) and CD45 (0.64%) (Fig. 1I ). In addition, following induction in osteogenic medium for 7 days and 14 days, DFSCs formed mineralized nodules that were visualized by Alizarin Red staining ( Fig. 1E and 1F ). After culture in adipogenic induction medium for 7 days and 14 days, DFSCs formed lipid droplets visualized by Oil Red O staining ( Fig. 1G and 1H ). These results demonstrated the multipotent differentiation ability of DFSCs.
DFSC/DFSC-CM treatment attenuated lung inflammation of LPS-induced ALI
Histological analysis revealed that LPS significantly increased the inflammatory infiltrates compared with uninjured group. This inflammatory influx was attenuated by DFSC/DFSC-CM treatment ( Fig. 2A-2H ). The quantitative histopathology score confirmed the phenomenon (Fig. 2J) . We also found that DFSC/DFSC-CM treatment prevented the lung vascular permeability of ALI, as assessed by dry / wet ratio (Fig. 2I) . The same trends were observed for the inflammatory cytokine levels in the BALF. At 24 h after LPS was administered, the levels of MCP-1, IL-1, IL-6 and TNF-α were significantly increased. When DFSC/DFSC-CM treatment was administered, the level of IL-10 increased remarkably, while the levels of MCP-1, IL-1 and TNF-α decreased, indicating attenuated inflammation (Fig. 2K-2O ). Consistent with these observations, immunofluorescence analysis revealed an increased accumulation of CD11b Fig. 2P and 2Q ). There was no statistical difference between DFSC and DFSC-CM treatment groups, suggesting that most of the DFSC-mediated therapeutic effects were elicited through paracrine mechanisms.
DFSC-CM induced M2 macrophage polarization
In order to detect more thoroughly the occurrence of DFSC-CM-induced alternative macrophage activation in vivo, we employed an in vitro inflammation model using NR8383 macrophages. Macrophages exhibit dramatic changes in cell morphology in different polarization in vitro; specifically, M2-polarized cells exhibit elongated shapes compared to Ml-polarized cells [41] . We found that macrophages cultured in Ham's F-12K medium maintained a spherical cell shape, whereas macrophages cultured with DFSC-CM exhibited an elongated shape with/without LPS infection (Fig. 3A) . LPS infection increased the transcription and secretion of the pro-inflammatory cytokines MCP-1, IL-1, IL-6 and TNF-α, as well as the anti-inflammatory cytokines IL-10, for 12 or 24 h, respectively. DFSC-CM treatment inhibited the production of the pro-inflammatory cytokines MCP-1, IL-1, IL-6 and TNF-α, whereas promoted the production of the anti-inflammatory cytokine IL-10 ( Fig.  3B~3K) . Furthermore, flow cytometric analysis showed that LPS upregulated the expression of the M1-polarizing surface marker CD86, whereas DFSC-CM treatment downregulated it (Fig. 4A) . Equally, LPS downregulated the expression of the M2-polarizing surface marker CD163, whereas DFSC-CM treatment upregulated it (Fig. 4B) . The macrophage polarization was further investigated using real-time PCR and western blot for the prototypical M1 and M2 markers, inducible nitric oxide synthase (iNOS) and Arg-1 [42] . When cultured in DFSC-CM with LPS stimuli, macrophages exhibited significant upregulation of Arg-1 and downregulation of iNOS, whereas macrophages cultured in Ham's F-12K medium with LPS infection expressed high levels of iNOS but not Arg-1 at both the transcriptional and translational levels (Fig. 4C~4G) . 
A protein array identified potential effective factors
We performed a protein array to identify potential effective soluble factors involved in the effects of the DFSC-CM, with Ham's F-12K medium as the control. The results showed that there were 42 differentially expressed proteins between the two groups (Fig. 5A~5C) , including growth factors, cytokines, chemokines, matricellular proteins, transmembrane proteins and neurotransmitters (Table 2) . Among the 42 proteins, TGF-β3 and Thrombospondin-1 (TSP-1), which were significantly higher in DFSC-CM than in Ham's F-12K medium (18-and 105-fold, respectively. Fig. 5C ), have previously been shown to exhibit important immunomodulatory activities [43] [44] [45] [46] . 
TSP-1 and TGF-β3 played a modulatory role in macrophage M2 polarization
We further confirmed the array results by performing ELISA on TSP-1 and TGF-β3 and explored the roles of TSP-1 and TGF-β3 in macrophage polarization. Specific neutralizing antibodies of TSP-1 and TGF-β3 were added to the DFSC-CM, and the neutralization effects were verified by ELISA (Fig. 6A and 6B ). Quantitative PCR assays showed that the inhibitory effect of DFSC-CM on IL-6 transcription was attenuated by the TGF-β3 neutralizing antibody but not the TSP-1 neutralizing antibody (Fig. 6C) , whereas TNF-α was unchanged when either the TSP-1 or TGF-β3 neutralizing antibody was used (Fig. 6D) . Intriguingly, the DFSC-CM-mediated enhancement of IL-10 expression was partly inhibited when both TSP-1 and TGF-β3 neutralizing antibodies were used (Fig. 6E) . Western blot analysis showed that DFSC- 
Discussion
In the present study, we provide evidence that the therapeutic benefits of DFSCs are due to paracrine mechanisms. The intravenous administration of DFSC-CM reduced the lung edema and inflammatory injury in vivo, this effect was comparable with the administration of an equivalent number of DFSCs. And DFSC-CM induced an anti-inflammatory M2 translation of macrophages exposed to LPS in vitro and in vivo. We also identified a previously unrecognized set of M2-like macrophage inducers, TGF-β3 and TSP-1, by secretome analysis of the DFSC-CM.
In the development of ALI, neutrophils and macrophages are activated to eliminate pathogens, however, it brings tissue damage by releasing antimicrobial compounds at the same time [31] . Monocyte chemoattractant protein-1 (MCP-1), also known as CCL2, is closely related to the recruitment of macrophages to the lungs [47] and prolonged elevation of inflammatory cytokines in ALI [48] . In the present study, MCP-1 was suppressed in vitro in macrophages and in rat models of ALI after DFSC-CM treatment, which would contribute to the reduction of the infiltration of inflammatory cells in vivo. Our results are in good agreement with previous studies demonstrating that MCP-1 is essential for inflammatory infiltration in ALI [47, 48] and other reports showing that MSC treatment remarkably decreased the injury score and neutrophil infiltration in the lung [30, 49] . Our data demonstrated the antiinflammatory effects of DFSCs and DFSC-CM, at least to some extent, based on their ability to inhibit inflammatory infiltration.
The present study suggests that DFSCs and DFSC-CM promote anti-inflammatory macrophages M2 translation. Ionescu et al. have reported that the activation of M2 macrophages is one of the mechanisms by which MSCs alleviate lung injury [32] . In consistent with their reports, we found that alveolar macrophages from lungs treated with DFSCs and DFSC-CM had elevated expression of M2 macrophage-specific marker Arg-1 compared with that of untreated LPS rats. Our further study also showed that in the in vitro inflammation model using NR8383 macrophages, DFSC-CM treatment reduced the release of the pro-inflammatory cytokines IL-1β, IL-6 and TNF-α and increased the release of the anti-inflammatory cytokine IL-10 under LPS stimulation. In addition, when LPS-treated macrophages were exposed to DFSC-CM, the expression levels of M2 macrophage-specific markers CD163 and Arg-1 increased, whereas the expression of M1 macrophage-specific markers CD86 and iNOS decreased. To the best of our knowledge, we demonstrated here for the first time that DFSCs promoted the macrophage polarization towards the M2 phenotype through paracrine effects.
Indeed, the paracrine mode of MSCs opens up new therapeutic perspectives. Various soluble factors secreted by MSCs, including IL-4 [50] , IL-13 [51] , prostaglandin E2 (PGE2) [52] , and tumor necrosis factor-α-induced gene/protein 6 (TSG-6) [53] , have been shown to play a critical role in modulating inflammatory processes and macrophage polarization towards the M2 phenotype in animal models of sepsis [54] , acute kidney injury [17] , experimental colitis [18] , spinal cord injury [19] , and skin wounds [1] . To determine the key factors responsible for macrophage polarization towards the M2 phenotype induced by DFSC-CM, we performed a protein array, which revealed that rDFSCs could release many secreted proteins, including immunomodulatory factors, growth factors, cytokines, chemokines and neurotrophic factors, thus providing useful information for future studies. In a similar manner, Schinköthe et al [55] . analyzed the secreting profile of human MSCs to attain the first large range of factors they secrete and categorized these into functional groups: immunosuppressive, angiogenic, anti-apoptotic, and pro-proliferative factors. Intriguingly, among factors that may account for the macrophage polarity conversion, we found that DFSC-CM did not contain classical M2-inducers. Based on bioinformatics analysis, TGF-β3 and TSP-1 were implied to be candidate molecules for further studies.
Studies have shown both pro-and anti-inflammatory functions of TGF-β3 [56, 57] , indicating its distinctive contributions to immunological activities. TGF-β3 could promote scar-free repair in wound healing, which highlighted its anti-inflammatory effect and therapeutic potential [58] [59] [60] . Our present study showed that DFSC-CM was rich in TGF-β3 and inhibited IL-6 production of LPS-treated macrophages via it in vitro, which was consistent with a previous study showing that TGF-β3 significantly suppressed both IL-6 transcripts and secretion in human cleft lip and palate fibroblasts [61] . Intriguingly, IL-6 levels were not significantly reduced post-DFSC/DFSC-CM treatment in vivo, which was Cellular Physiology and Biochemistry
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contrary to a recent finding that MSCs treatment decreased IL-6 levels in the BALF after S. pneumoniae induced ALI [62] . We speculate that this might be on account of that the effect of MSCs on IL-6 production varies depending on the bacterial species [63] . Another possible reason is that in vitro conditions only reflected the macrophage responses, and other cells like neutrophils [64] can also contribute to IL-6 production in vivo, leading to differences between in vitro and in vivo results. Furthermore, our findings that the incubation of DFSC-CM with a neutralizing anti-TGF-β3 antibody reduced the expression of the M2 polarization marker Arg-1 indicated that TGF-β3 might play a role in DFSC-CM-directed macrophage M2 polarization, even though the expression of the M1 polarization marker iNOS was not affected. Further studies are needed to reveal the underlying mechanisms. To the best of our knowledge, the present study was the first to uncover the potential roles of DFSC-secreted TGF-β3 in macrophage polarization switch. TSP-1, a member of the matricellular TSP protein family, is secreted by a variety of normal and transformed cells [65] . A significant high level of TSP-1 was observed in DFSC-CM. Targeting TSP-1 with a specific neutralizing antibody had a measurable impact on Arg-1 expression of macrophages, which was consistent with previous studies by Chen and colleagues showing that the absence of TSP-1 led to an increase in the ratio of Arg-1 -CD68 + M1 macrophages in a mouse autoimmune uveoretinitis model [44] . These results suggested that TSP-1 could promote the expression of Arg-1, but the specific mechanism has not yet been revealed. In addition, previous studies showed that by disrupting the interaction between CD47 and CD14 on human macrophages, TSP-1 limited the activation of NF-κB/AP-1 by LPS, resulting in inhibition of inflammatory cytokine production [43] . In the present study, however, addition of neutralizing antibodies against TSP-1 to DFSC-CM had little effect on the expression levels of IL-6, TNF-α and iNOS of macrophages, which may be due to the different regulatory effects of TSP-1 in different environments [43, 66, 67] . Intriguingly, we found that IL-10 expression was not significantly reduced by the addition of either TGF-β3 or TSP-1 neutralizing antibodies, but IL-10 was significantly inhibited when both neutralizing antibodies were added to DFSC-CM. These findings indicated that TGF-β3 and TSP-1 might have a synergistic effect on IL-10 expression of macrophages. Yehualaeshet et al. demonstrated that TSP-1 could interact with and convert latent TGF-β1 into active TGF-β1 [68] , indicating a crosstalk between TSP-1 and TGF-β1. Since TGF-β3 and TGF-β1 share a similar structure, ligand binding site and biological features [69] , there might also be an interaction between TGF-β3 and TSP-1 that synergistically promoted IL-10 expression.
Notably, DFSC-CM also contained significantly increased levels of potential protective factors, suggesting that other mechanisms might explain the therapeutic benefits of DFSC-CM in this model. TIMP-1 was increased 87-fold in DFSC-CM compared with control medium. TIMP-1 is the major endogenous regulator of matrix metalloproteinase with an important role in improving wound healing through its pro-proliferation and anti-apoptosis effects [70] . Another molecule, TRAIL, was increased 23-fold in DFSC-CM compared with control medium. TRAIL mediates the anti-inflammatory benefits by inhibiting the proliferation and activation of T cells in the peripheral immune system [71, 72] . We also found that AMPK-α1 was increased 10-fold in DFSC-CM compared with control medium. AMPK-α1 is crucial in regulating metabolism [73] . Recent study shows that metformin alleviates capillary injury during LPS-induced ALI via AMPK-α1 [74] . A 3-fold increase of FGF-2 was observed in DFSC-CM compared with control group. Mice treated with FGF-2-loaded heparin-conjugated fibrin showed significantly reduced inflammation and enhanced neovascularization [75] .Therefore, TIMP-1, TRAIL, AMPK-α1, FGF-2 and many others might also be of vital importance in antiinflammatory effects in DFSC-CM although it still needs further study.
Conclusion
Taken together, our data provides direct in vivo and in vitro evidence that DFSCs exert their therapeutic benefits through a paracrine way. We have identified a novel set of M2 inducers, TSP-1 and TGF-β3, from DFSC-CM. These findings support the hypothesis that DFSCs, a unique population of dental-derived MSCs with accessible tissue source, ease of isolation and rapid proliferation, are a promising cell source for MSC-based immunotherapy.
Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry
